MedCath Announces Filing Of Certification On Form 15 To Suspend Its
Reporting Obligations Under Section 15(d) Of The Securities
Exchange Act Of 1934
CHARLOTTE, N.C., Oct. 29, 2012 /PRNewswire/ -- MedCath Corporation
(the "Company") announced today it intends to file with the
Securities and Exchange Commission (the "SEC") on or before
October 30, 2012, a Certification and
Notice of Termination of Registration Under Section 12(g) of the
Securities Exchange Act of 1934 (the "Exchange Act") or Suspension
of Duty to File Reports under Sections 13 and 15(d) of the Exchange
Act on Form 15. The Company is filing the Form 15 to
terminate the registration under section 12(g) of the Exchange Act
of both the Company's common stock, $.01 par value (the "Common Stock"), and the
preferred stock purchase rights attached to the Common Stock.
The Company is also filing the Form 15 to notify the SEC of the
suspension of the Company's periodic reporting obligation under
Section 15(d) of the Exchange Act as to its fiscal year beginning
October 1, 2012, as of which date the
Company had fewer than 300 security holders of record.
The Company is not obligated to and will not file current and
periodic reports with the SEC for its current fiscal year and does
not expect to be obligated to do so in any subsequent fiscal year,
but the Company is obligated to file an Annual Report on Form 10-K
for its previous fiscal year, which ended September 30, 2012. The Company expects to
file that Annual Report on December 14,
2012.
The Company previously filed a Certificate of Dissolution with
the Delaware Secretary of State
(the "Dissolution Filing") that became effective as of 5:00 p.m., Eastern Time, September 21, 2012. The NASDAQ Stock
Market LLC ("NASDAQ") filed with the SEC on September 21, 2012 a Notice of Removal from
Listing and/or Registration on Form 25 to delist the Company's
common stock from NASDAQ.
Upon the effectiveness of the Dissolution Filing, the Company
closed its stock transfer books and discontinued recording
transfers of its Common Stock, except for transfers by will,
intestate succession or operation of law. From and after the
effectiveness of the Dissolution Filing, the Company's stockholders
have only such rights and obligations as provided under the
Delaware General Corporation Law for stockholders of a dissolved
corporation.
Although the Company will no longer be filing current and
periodic reports with the SEC, the Company intends to post
periodically on its website a statement of net assets and a
statement of changes in net assets and to post from time to time
information about any material developments with respect to
significant transactions for disposing of the Company's remaining
assets, any significant developments in claims, litigation,
investigations and any other future events that could materially
impact the timing or amount of liquidating distributions, if any,
to be made to the Company's stockholders of record as of the
effectiveness of the Filing.
About MedCath
MedCath Corporation, headquartered in Charlotte, N.C., was a health care provider
focused on high acuity services with the diagnosis and treatment of
cardiovascular disease being a primary service offering. Having now
divested all of its hospitals and made the Dissolution Filing,
MedCath is focused on realizing the value of its remaining
immaterial assets, making tax and regulatory filings, winding down
its business affairs, managing its known and unknown contingencies,
and seeking to make distributions, if any, to its stockholders as
part of its plan of dissolution.
SOURCE MedCath Corporation